当前位置: 首页 > 医疗版 > 疾病专题 > 内分泌科 > 糖尿病
编号:13234586
部分miRNA在糖尿病性心肌病病理生理过程中的作用(5)
http://www.100md.com 2018年3月15日 《中国医学创新》 2018年第8期
     [21] Hathaway Q A,Pinti M V,Durr A J,et al.Regulating MicroRNA Expression:At the Heart of Diabetes Mellitus and the Mitochondrion[J].Am J Physiol Heart Circ Physiol,2018,314(2):520-2017.

    [22] Saito S,Thuc L C,Teshima Y,et al.Glucose Fluctuations Aggravate Cardiac Susceptibility to Ischemia/Reperfusion Injury by Modulating MicroRNAs Expression[J].Circ J,2016,80(1):186-195.

    [23] Yildirim S S,Akman D,Catalucci D,et al.Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction:junctin as a target protein of miR-1[J].Cell Biochem Biophys,2013,67(3):1397-1408.

    [24] Greco S,Fasanaro P,Castelvecchio S,et al.MicroRNA dysregulation in diabetic ischemic heart failure patients[J].Diabetes,2012,61(6):1633-1641.

    [25] Raut S K,Singh G B,Rastogi B,et al.miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy[J].Mol Cell Biochem,2016,417(1-2):191-203.

    [26] Liu X,Liu S.Role of microRNAs in the pathogenesis of diabetic cardiomyopathy[J].Biomed Rep,2017,6(2):140-145.

    [27] Raut S K,Kumar A,Singh G B,et al.miR-30c Mediates Upregulation of Cdc42 and Pak1 in Diabetic Cardiomyopathy[J].Cardiovasc Ther,2015,33(3):89-97.

    (收稿日期:2017-12-13) (本文編辑:程旭然), 百拇医药(叶小林 李涛 吴柱国)
上一页1 2 3 4 5


    参见:首页 > 医疗版 > 疾病专题 > 内分泌科 > 糖尿病